Story of time
Release time:
2020-08-14
Story of Time
■ Jin Xi Factory Zhang Zhijian
Time flies. It seems that it is only a twinkling of an eye that I have been in peak for 20 years. In the past 20 years, I have been working, studying and growing up. Little by little, my experience is the most precious wealth in my life.
In 1996 5 , I was lucky enough to be a member of the peak. I came to Jinguo Cement Plant (later Jinma Cement Plant) and was assigned to the coal mill position in the firing workshop. The production line of Jinguo Cement Plant was the first batch of rotary kilns in Zhejiang Province. At that time, the equipment was still being debugged. On the second day of work, I received the task of adding steel balls to the ball mill. When I saw that pile of steel balls, I was dumbfounded -- it was so heavy, so big, when would it be added? Fortunately, the squad leader had a way to lead us to line up between the mill and the ball pile, and put the steel balls into the machine one by one. After a busy morning, after a hastily finished lunch, everyone moved it again without taking a rest. I was busy until I got off work and finally finished the task. Although everyone was tired, they were all very happy because the trial production was about to ignite. Now I think of the joy of everyone when the ignition was successful, it seems like yesterday.
worked in the cement factory for less than a year, 1997 3 , I was transferred to Jianfeng Kangjie Chemical Co., Ltd., which was later Jiangnan Pharmaceutical Branch. The pharmaceutical factory has a beautiful environment, a high degree of automation in the production line, and it works indoors and has air conditioning, which is incomparable to the cement factory at that time. I made up my mind to work hard and live up to the company's trust.
In 2004 , the factory assigned me to be responsible for the procurement of raw materials. At that time, due to changes in the general environment, drug prices were repeatedly lowered. To control production costs, it was the most direct and important way to purchase raw and auxiliary materials. For this reason, I bargain with the supplier again and again, and try my best to "compress" the price under the premise of ensuring the quality. After hard work, only two raw materials, cefuroxime sodium and azithromycin, saved the purchase cost of ,200 yuan that year. However, good things took a long time. In that year, the company's funds were relatively tight, and sometimes the payment for goods was not timely enough. I tried every possible means to negotiate with the suppliers to win their understanding and support, extend the payment period, and ease the financial pressure in the factory.
In 2005 , the sales volume of cefmenoxime for injection, the main product, was increasing, and the amount of wastewater generated by production was also increasing, far exceeding the treatment capacity of the environmental protection facilities of Jiangnan Factory at that time, so it could only be pulled to Qiubin Pharmaceutical Factory for sewage treatment. Waste water 50 kg is a big barrel. Jiang Guomin and I are carrying, loading and unloading together, every day. The smell of waste water is very strong, it is disgusting to smell, and it is even more uncomfortable to splash on clothes and trousers, and it is even more unbearable in summer. However, we did not complain at all and handled it properly in time to ensure that the factory passed the environmental protection test smoothly. It was also that year that I was named the first gold medal employee by the group company.
In 2006 , I served as the warehouse monitor of Jiangnan Factory. Warehouse management is very trivial. As long as I have time, I will soak in the warehouse to check the storage and quality of various materials, and report problems to relevant departments in time. On one occasion, the azithromycin packing box sent by the printing factory was mistakenly printed as "Qi". After finding the problem, I immediately contacted the manufacturer to return it and redo it. In the management of pharmaceutical production GMP , the warehouse is also a very important link, so together with the warehouse keeper, I did a good job in the acceptance, warehousing, storage and distribution of materials in strict accordance with the specifications, and successfully passed the previous certification inspection. In normal work, if we find that there are raw and auxiliary materials, packaging materials or finished product quality inspection forms that have not arrived, we should also do a good job in linking up with the laboratory work. On one occasion, a batch of cefmenoxime had to be delivered in a hurry, but the quality inspection form was not yet in place. I contacted the central laboratory and learned that it had been opened. I rode my bike to get it back immediately without delaying the delivery.
From Jinguo Cement Company to Kangjie Chemical Company, and from Jiangnan Factory to Jinxi Factory now, along the way, I have witnessed the ups and downs in the process of peak development, tears and laughter, confusion and emotion, but what is more in my heart is a persistence-persisting in studying and striving to improve my business level. Adhere to strict demands on yourself, do every job well in a down-to-earth and conscientious manner. The spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top and climb the peak forever" promotes the continuous development of the peak cause and makes me grow up with the peak.
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31